Organization
Ribomic USA
2 clinical trials
Clinical trial
A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of RBM-007 Monotherapy and RBM-007 in Combination With Eylea® Compared to Eylea® MonotherapyStatus: Completed, Estimated PCD: 2021-11-19
Clinical trial
A Multi-Center, Open Label, TOFU Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular DegenerationStatus: Completed, Estimated PCD: 2021-11-19